Skin conductance measurement for the assessment of analgosedation adequacy in infants treated with mechanical

Wojciech Walas1, Zenon Halaba2, Agata Kubiaczyk3

  • 1Pediatric and Neonatal Intensive Care Unit, University Hospital in Opole, Poland.

Insights

Skin conductance (SC) monitoring shows promise for assessing pain and sedation in ventilated infants. This method correlates with the COMFORT-B scale, helping to identify deep sedation levels in neonatal/pediatric intensive care units.

Area of Science:

  • Neonatal and Pediatric Intensive Care
  • Pain Management
  • Physiological Monitoring

Background:

  • Neonatal/pediatric intensive care unit (N/PICU) patients often experience pain, necessitating effective assessment methods.
  • Current behavioral and physiological scales for pain severity have limitations.
  • Additional methods are needed to accurately assess analgesia and sedation in these vulnerable patients.

Purpose of the Study:

  • To evaluate the utility of skin conductance (SC) measurement for assessing analgosedation quality in infants requiring mechanical ventilation.
  • To compare SC measurements with existing clinical assessment tools.

Main Methods:

  • A study involving 30 mechanically ventilated infants (6-208 days old) receiving analgosedation in N/PICUs.
  • Simultaneous measurement of skin conductance using the SCA (skin conductance algesimeter) monitor and COMFORT-B scale assessments.
  • Analysis of 412 paired SC measurements and COMFORT-B scores from 29 patients.

Main Results:

  • A statistically significant correlation was observed between COMFORT-B scores and SC measurements.
  • SC levels were significantly lower during periods of deep sedation compared to moderate or insufficient sedation.

Conclusions:

  • Skin conductance measurements are a viable alternative to the COMFORT-B scale for assessing analgosedation in ventilated infants.
  • The SCA monitor can aid in evaluating analgosedation quality, particularly in identifying deep sedation.
  • Further research is recommended to confirm the clinical applicability of the SCA monitor.
Abstract